(NASDAQ: CDNA) Caredx's forecast annual revenue growth rate of 9.51% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 8.6%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 17%.
Caredx's revenue in 2026 is $412,820,000.On average, 9 Wall Street analysts forecast CDNA's revenue for 2026 to be $24,023,725,044, with the lowest CDNA revenue forecast at $22,974,004,390, and the highest CDNA revenue forecast at $24,792,934,716. On average, 8 Wall Street analysts forecast CDNA's revenue for 2027 to be $25,400,450,213, with the lowest CDNA revenue forecast at $21,842,661,756, and the highest CDNA revenue forecast at $27,766,971,038.
In 2028, CDNA is forecast to generate $27,339,230,535 in revenue, with the lowest revenue forecast at $24,002,028,062 and the highest revenue forecast at $29,405,093,180.